In this episode of CME on the go, recorded live at FMX in Anaheim, our hosts discuss the complexities of ADHD treatment. They cover initial thoughts on stimulant and non-stimulant medications, dosing guidelines, and the importance of addressing comorbid conditions. Listeners' feedback from a previous ADHD episode is highlighted, emphasizing the need for practical prescribing insights. The hosts also discuss the relevance of shared decision-making and strategies for managing ADHD amid potential substance abuse risks.  

After listening to the podcast episode, claim 0.5 AAFP credit by following the provided link. 

https://www.aafp.org/assessment/take/19540/e

Learning Objectives  

1. Design efficient workflows for managing controlled substances in ADHD treatment, balancing regulatory requirements with patient care.  
2. Analyze the pharmacology, clinical applications, and abuse potential of stimulant medications, including considerations for off-label use and misuse in non-ADHD populations.
3. Integrate ADHD medications into treatment plans for patients with comorbid psychiatric conditions, such as depression, to enhance overall therapeutic outcomes. 

References and Resources 

https://chadd.org/for-adults/medication-management/ 

Chang Z, Lichtenstein P, Halldner L, et al. Stimulant ADHD medication and risk for substance abuse. J Child Psychol Psychiatry. 2014;55(8):878-885. doi:10.1111/jcpp.12164 

https://chadd.org/for-parents/substance-abuse-and-adhd/ 

Volkow ND, Swanson JM. Does childhood treatment of ADHD with stimulant medication affect substance abuse in adulthood?. Am J Psychiatry. 2008;165(5):553-555. doi:10.1176/appi.ajp.2008.08020237 

Journal of Child and Adolescent PsychopharmacologyVol. 32, No. 4 

Published Online: 17 May 2022 

The Impact of Pharmacotherapy of Childhood-Onset Psychiatric Disorders on the Development of Substance Use Disorders 

Authors: Timothy E. Wilens https://orcid.org/0000-0002-5749-8503 twilens@mgh.harvard.edu, Diana W. Woodward, Je Deuk Ko, Amy F. Berger, Colin Burke, and Amy M. Yule 

Molina BSG, Kennedy TM, Howard AL, et al. Association Between Stimulant Treatment and Substance Use Through Adolescence <span class="NormalTextRun ContextualSpellingAndGrammarErrorV2Them